Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Dierdre Smith-Russell & Sarah Bowen. (2023) Mediating Effects of Thought Suppression in the Relationship Between Mindfulness and Substance Use Craving. Substance Use & Misuse 58:10, pages 1196-1201.
Read now
Read now
Jermaine D. Jones, Adam Bisaga, Verena E. Metz, Jeanne M. Manubay, Shanthi Mogali, Roberto Ciccocioppo, Gabriela Madera, Molly Doernberg & Sandra D. Comer. (2018) The PPARγ Agonist Pioglitazone Fails to Alter the Abuse Potential of Heroin, But Does Reduce Heroin Craving and Anxiety. Journal of Psychoactive Drugs 50:5, pages 390-401.
Read now
Read now
Sunil Sirohi & Amit K Tiwari. (2016) Pain in the management of opioid use disorder. Journal of Pain Research 9, pages 963-966.
Read now
Read now
Lisham Ashrafioun. (2016) Prescription Opioid Craving: Relationship With Pain and Substance Use-Related Characteristics. Substance Use & Misuse 51:11, pages 1512-1520.
Read now
Read now
Articles from other publishers (38)
Samuel W. Stull, Ashley N. Linden‐Carmichael, Christy K. Scott, Michael L. Dennis & Stephanie T. Lanza. (2023) Time‐varying effect modeling with intensive longitudinal data: Examining dynamic links among craving, affect, self‐efficacy and substance use during addiction recovery. Addiction 118:11, pages 2220-2232.
Crossref
Crossref
Xinyi Li, Daniel D. Langleben, Kevin G. Lynch, Gene-Jack Wang, Igor Elman, Corinde E. Wiers & Zhenhao Shi. (2023) Association between body mass index and treatment completion in extended-release naltrexone-treated patients with opioid dependence. Frontiers in Psychiatry 14.
Crossref
Crossref
Stefanie F. Gonçalves, Alyssa M. Izquierdo, Rebecca A. Bates, Angeela Acharya, Holly Matto & Siddhartha Sikdar. (2023) Negative Urgency Linked to Craving and Substance Use Among Adults on Buprenorphine or Methadone. The Journal of Behavioral Health Services & Research.
Crossref
Crossref
Catherine Baxley, Brian Borsari, Jill V. Reavis, Jennifer K. Manuel, Ellen Herbst, William Becker, David Pennington, Steven L. Batki & Karen Seal. (2023) Effects of buprenorphine on opioid craving in comparison to other medications for opioid use disorder: A systematic review of randomized controlled trials. Addictive Behaviors 139, pages 107589.
Crossref
Crossref
Kyle R. Samson, Wei Xu, Sandhya Kortagere & Rodrigo A. España. (2022) Intermittent access to oxycodone decreases dopamine uptake in the nucleus accumbens core during abstinence. Addiction Biology 27:6.
Crossref
Crossref
Irina A. Strigo, Emily Murphy, Jennifer M. Mitchell & Andrea D. Spadoni. (2022) Learning from addiction: Craving of prescription opioids in chronic pain sufferers. Neuroscience & Biobehavioral Reviews 142, pages 104904.
Crossref
Crossref
Orrin D. Ware, Jennifer D. Ellis, Kelly E. Dunn, J. Gregory Hobelmann, Patrick Finan & Andrew S. Huhn. (2022) The association of chronic pain and opioid withdrawal in men and women with opioid use disorder. Drug and Alcohol Dependence 240, pages 109631.
Crossref
Crossref
Jennifer D. Ellis, Chung Jung Mun, David H. Epstein, Karran A. Phillips, Patrick H. Finan & Kenzie L. Preston. (2022) Intra-individual variability and stability of affect and craving among individuals receiving medication treatment for opioid use disorder. Neuropsychopharmacology 47:10, pages 1836-1843.
Crossref
Crossref
Katherine Shircliff, Melissa Liu, Christiana Prestigiacomo, Melissa Fry, Kevin Ladd, Misty Kannapel Gilbert, Mary Jo Rattermann & Melissa A. Cyders. (2022) Mixed methods prospective findings of the initial effects of the U.S. COVID-19 pandemic on individuals in recovery from substance use disorder. PLOS ONE 17:7, pages e0270582.
Crossref
Crossref
Kathryn Biernacki, Silvia Lopez-Guzman, John C. Messinger, Nidhi V. Banavar, John Rotrosen, Paul W. Glimcher & Anna B. Konova. (2021) A neuroeconomic signature of opioid craving: How fluctuations in craving bias drug-related and nondrug-related value. Neuropsychopharmacology 47:8, pages 1440-1448.
Crossref
Crossref
Sarah Gerhardt, Katharina Eidenmueller, Sabine Hoffmann, Nina K. Bekier, Patrick Bach, Derik Hermann, Anne Koopmann, Wolfgang H. Sommer, Falk Kiefer & Sabine Vollstädt-Klein. (2022) A History of Childhood Maltreatment Has Substance- and Sex-Specific Effects on Craving During Treatment for Substance Use Disorders. Frontiers in Psychiatry 13.
Crossref
Crossref
Albert J. Burgess-Hull, Leigh V. Panlilio, Kenzie L. Preston & David H. Epstein. (2022) Trajectories of craving during medication-assisted treatment for opioid-use disorder: Subtyping for early identification of higher risk. Drug and Alcohol Dependence 233, pages 109362.
Crossref
Crossref
Alison C. Lynch, Andrea N. Weber, Suzy Hedden, Sayeh Sabbagh, Stephan Arndt & Laura Acion. (2021) Three-month outcomes from a patient-centered program to treat opioid use disorder in Iowa, USA. Substance Abuse Treatment, Prevention, and Policy 16:1.
Crossref
Crossref
Marco Venniro, Ingrid Reverte, Leslie A. Ramsey, Kimberly M. Papastrat, Ginevra D’Ottavio, Michele Stanislaw Milella, Xuan Li, Jeffrey W. Grimm & Daniele Caprioli. (2021) Factors modulating the incubation of drug and non-drug craving and their clinical implications. Neuroscience & Biobehavioral Reviews 131, pages 847-864.
Crossref
Crossref
Sylwia Opozda-Suder, Kinga Karteczka-Świętek & Małgorzata Piasecka. (2021) Psychometric properties and longitudinal measurement invariance of the drug craving scale: Modification of the Polish version of the Penn Alcohol Craving Scale (PACS). PLOS ONE 16:9, pages e0256018.
Crossref
Crossref
Nina A. Cooperman, Adam W. Hanley, Anna Kline & Eric L. Garland. (2021) A pilot randomized clinical trial of mindfulness-oriented recovery enhancement as an adjunct to methadone treatment for people with opioid use disorder and chronic pain: Impact on illicit drug use, health, and well-being. Journal of Substance Abuse Treatment 127, pages 108468.
Crossref
Crossref
Tanya C. Saraiya, Amber M. Jarnecke, Jennifer Jones, Delisa G. Brown, Kathleen T. Brady & Sudie E. Back. (2021) Laboratory-induced stress and craving predict opioid use during follow-up among individuals with prescription opioid use disorder. Drug and Alcohol Dependence 225, pages 108755.
Crossref
Crossref
Chung Jung Mun, Patrick H. Finan, David H. Epstein, William J. Kowalczyk, Daniel Agage, Janelle E. Letzen, Karran A. Phillips & Kenzie L. Preston. (2020) Craving mediates the association between momentary pain and illicit opioid use during treatment for opioid‐use disorder: an ecological momentary assessment study. Addiction 116:7, pages 1794-1804.
Crossref
Crossref
Sofia Vicente, Laura Inês Ferreira, Antonia María Jiménez-Ros, Cláudia Carmo & Luís Janeiro. (2021) The therapist, the group and I: how therapeutic alliance moderates the effect of group cohesion on outcomes. Therapeutic Communities: The International Journal of Therapeutic Communities 42:1, pages 68-78.
Crossref
Crossref
Kayla M. Scamaldo, Matthew T. Tull & Kim L. Gratz. (2021) Motives for opioid use explain the relation between borderline personality disorder pathology and opioid use problems. Psychiatry Research 296, pages 113609.
Crossref
Crossref
Mary Jean Costello, Chris Viel, Yao Li, Assaf Oshri & James MacKillop. (2020) Psychometric validation of an adaptation of the Penn Alcohol Craving Scale to assess aggregated drug craving. Journal of Substance Abuse Treatment 119, pages 108127.
Crossref
Crossref
Lindsay M. Lueptow, Elizabeth C. Shashkova, Margaret G. Miller, Christopher J. Evans & Catherine M. Cahill. (2020) Insights into the Neurobiology of Craving in Opioid Use Disorder. Current Anesthesiology Reports 10:4, pages 378-387.
Crossref
Crossref
Marco Cavicchioli, Giulia Vassena, Mariagrazia Movalli & Cesare Maffei. (2020) Is craving a risk factor for substance use among treatment-seeking individuals with alcohol and other drugs use disorders? A meta-analytic review. Drug and Alcohol Dependence 212, pages 108002.
Crossref
Crossref
Mirinda Ann Gormley, Courtney T Blondino, DaShaunda D H Taylor, Elizabeth Lowery, James S Clifford, Benjamin Burkart, Whitney C Graves, Elizabeth C Prom-Wormley & Juan Lu. (2020) Assessment of Co-Occurring Substance Use During Opiate Treatment Programs in the United States. Epidemiologic Reviews 42:1, pages 79-102.
Crossref
Crossref
Courtney T Blondino, Mirinda Ann Gormley, DaShaunda D H Taylor, Elizabeth Lowery, James S Clifford, Benjamin Burkart, Whitney C Graves, Juan Lu & Elizabeth C Prom-Wormley. (2020) The Influence of Co-Occurring Substance Use on the Effectiveness of Opiate Treatment Programs According to Intervention Type. Epidemiologic Reviews 42:1, pages 57-78.
Crossref
Crossref
Bethea A. Kleykamp, Marta De Santis, Robert H. Dworkin, Andrew S. Huhn, Kyle M. Kampman, Ivan D. Montoya, Kenzie L. Preston, Tanya Ramey, Shannon M. Smith, Dennis C. Turk, Robert Walsh, Roger D. Weiss & Eric C. Strain. (2019) Craving and opioid use disorder: A scoping review. Drug and Alcohol Dependence 205, pages 107639.
Crossref
Crossref
R. Ross MacLean, Jessica L. Armstrong & Mehmet Sofuoglu. (2019) Stress and opioid use disorder: A systematic review. Addictive Behaviors 98, pages 106010.
Crossref
Crossref
Johan Kakko, Hannu Alho, Alexander Baldacchino, Rocío Molina, Felice Alfonso Nava & Gabriel Shaya. (2019) Craving in Opioid Use Disorder: From Neurobiology to Clinical Practice. Frontiers in Psychiatry 10.
Crossref
Crossref
Kenzie L Preston, William J Kowalczyk, Karran A Phillips, Michelle L Jobes, Massoud Vahabzadeh, Jia-Ling Lin, Mustapha Mezghanni & David H Epstein. (2017) Exacerbated Craving in the Presence of Stress and Drug Cues in Drug-Dependent Patients. Neuropsychopharmacology 43:4, pages 859-867.
Crossref
Crossref
Charles E Argoff, Daniel P Alford, Jeffrey Fudin, Jeremy A Adler, Matthew J Bair, Richard C Dart, Roy Gandolfi, Bill H McCarberg, Steven P Stanos, Jeffrey A Gudin, Rosemary C Polomano & Lynn R Webster. (2018) Rational Urine Drug Monitoring in Patients Receiving Opioids for Chronic Pain: Consensus Recommendations. Pain Medicine 19:1, pages 97-117.
Crossref
Crossref
Matthew C. Enkema & Sarah Bowen. (2017) Mindfulness practice moderates the relationship between craving and substance use in a clinical sample. Drug and Alcohol Dependence 179, pages 1-7.
Crossref
Crossref
Kenzie L. Preston, William J. Kowalczyk, Karran A. Phillips, Michelle L. Jobes, Massoud Vahabzadeh, Jia-Ling Lin, Mustapha Mezghanni & David H. Epstein. (2017) Context and craving during stressful events in the daily lives of drug-dependent patients. Psychopharmacology 234:17, pages 2631-2642.
Crossref
Crossref
David M. Lydon-Staley, H. Harrington Cleveland, Andrew S. Huhn, Michael J. Cleveland, Jonathan Harris, Dean Stankoski, Erin Deneke, Roger E. Meyer & Scott C. Bunce. (2017) Daily sleep quality affects drug craving, partially through indirect associations with positive affect, in patients in treatment for nonmedical use of prescription drugs. Addictive Behaviors 65, pages 275-282.
Crossref
Crossref
Judith I. Tsui, Marlene C. Lira, Debbie M. Cheng, Michael R. Winter, Daniel P. Alford, Jane M. Liebschutz, Robert R. Edwards & Jeffrey H. Samet. (2016) Chronic pain, craving, and illicit opioid use among patients receiving opioid agonist therapy. Drug and Alcohol Dependence 166, pages 26-31.
Crossref
Crossref
Hedy Kober & Maggie Mae Mell. 2015. The Wiley Handbook on the Cognitive Neuroscience of Addiction. The Wiley Handbook on the Cognitive Neuroscience of Addiction
195
218
.
Michael D. Stein, Debra S. Herman, Ethan Moitra, Jacki Hecht, Rosalie Lopez, Bradley J. Anderson & Richard A. Brown. (2015) A preliminary randomized controlled trial of a distress tolerance treatment for opioid dependent persons initiating buprenorphine. Drug and Alcohol Dependence 147, pages 243-250.
Crossref
Crossref
Daniel Bruns & John Mark Disorbio. (2014) The Psychological Evaluation of Patients with Chronic Pain: a Review of BHI 2 Clinical and Forensic Interpretive Considerations. Psychological Injury and Law 7:4, pages 335-361.
Crossref
Crossref
Richard A. Brown, Erika Litvin Bloom, Jacki Hecht, Ethan Moitra, Debra S. Herman & Michael D. Stein. (2014) A Pilot Study of a Distress Tolerance Treatment for Opiate-Dependent Patients Initiating Buprenorphine. Behavior Modification 38:5, pages 730-759.
Crossref
Crossref